CREID Coordinating Center
The CREID Coordinating Center is a partnership between RTI International (RTI) and Duke University’s Human Vaccine Institute (DHVI). Serving as the operational hub for the CREID Network, the RTI-Duke Coordinating Center team offers expertise in supporting administration and management of data and scientific programs. The CREID CC has extensive experience in international outbreak research response, including field experience responding to complex outbreaks. The team will maintain and grow existing relationships with domestic and international collaborators, including Ministries of Health (MOHs) and local research institutions. Additionally, the team will facilitate and coordinate relevant outreach to engage new partners.
To accomplish their mission, the CREID Coordinating Center provides scalable administrative and management systems, processes, and resources which will build the necessary infrastructure to promote CREID-Network research and carry out core functions during inter-outbreak periods. The CREID CC can also be enhanced and expanded to strengthen research surge response activities during outbreaks.
This Coordinating Center is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number 1U01AI151378
Nathan Vandergrift, PhD is a senior research statistician at RTI with more than 15 years of experience in collaborative research. He has led statistical teams covering diverse study areas including public health-related infectious disease, translational medicine, and vaccine development and treatment as well as pharmaceutical clinical trials, education and child development. His areas of statistical expertise include structural equation modeling, nonlinear and linear mixed-effects modeling, generalized linear models, nonparametric statistics, missing data, and statistical matching.
Dr. Vandergrift is currently the statistical lead for the HEALing Communities Study (HCS, the NIDA research effort into methods to decrease opioid overdose deaths) and leads the Statistics and Data Analysis Workgroup for the HCS consortium. These collaborations have resulted in publications accepted to highly regarded peer-reviewed journals. Before joining RTI, Dr. Vandergrift served as the Director of Biostatistics for the Duke Human Vaccine Institute and the Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI), and also served as the Statistics or Analytical core lead for several center grants including the Collaboratory of AIDS Researchers for Eradication (CARE).
Duke Human Vaccine Institute dhvi.duke.edu
As Program Lead for the Duke CIVICs Vaccine Center, Hilary oversees all programmatic aspects for the DHVI’s pre-clinical activities. She ensures milestones and deliverables are met on time, all activities performed are within scope of the program, financial expenditures are compliant, and communication, including planning and data-sharing, is seamless among all collaborators. Hilary has 13 years of experience as a pre-clinical laboratory manager prior to transitioning to program management. She has contributed to the successful management of multiple federal and foundation grants and contracts focusing on discovery science, including the NIH’s Center for HIV/AIDS Vaccine Immunology (CHAVI) grants and Bill and Melinda Gates Foundation (BMFG) grants.